IL193143A0 - Effectof bst2 inhibitor - Google Patents

Effectof bst2 inhibitor

Info

Publication number
IL193143A0
IL193143A0 IL193143A IL19314308A IL193143A0 IL 193143 A0 IL193143 A0 IL 193143A0 IL 193143 A IL193143 A IL 193143A IL 19314308 A IL19314308 A IL 19314308A IL 193143 A0 IL193143 A0 IL 193143A0
Authority
IL
Israel
Prior art keywords
effectof
bst2
inhibitor
effectof bst2
bst2 inhibitor
Prior art date
Application number
IL193143A
Other languages
English (en)
Original Assignee
Isu Abxis Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US11/471,853 external-priority patent/US7740856B2/en
Priority claimed from US11/757,329 external-priority patent/US20080299128A1/en
Application filed by Isu Abxis Co Ltd filed Critical Isu Abxis Co Ltd
Publication of IL193143A0 publication Critical patent/IL193143A0/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K19/00—Hybrid peptides, i.e. peptides covalently bound to nucleic acids, or non-covalently bound protein-protein complexes
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Immunology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
IL193143A 2006-06-20 2008-07-30 Effectof bst2 inhibitor IL193143A0 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US11/471,853 US7740856B2 (en) 2005-12-20 2006-06-20 Effect of BST2 on inflammation
US11/757,329 US20080299128A1 (en) 2006-06-20 2007-06-01 Effect of Bst2 on inflammation
PCT/US2007/014434 WO2008127261A1 (en) 2006-06-20 2007-06-20 Bst2 inhibitor

Publications (1)

Publication Number Publication Date
IL193143A0 true IL193143A0 (en) 2009-02-11

Family

ID=41050321

Family Applications (1)

Application Number Title Priority Date Filing Date
IL193143A IL193143A0 (en) 2006-06-20 2008-07-30 Effectof bst2 inhibitor

Country Status (7)

Country Link
JP (1) JP2009536952A (es)
KR (1) KR20110029181A (es)
CN (1) CN101516910A (es)
BR (1) BRPI0708042A2 (es)
IL (1) IL193143A0 (es)
MX (1) MX2008009830A (es)
RU (1) RU2419629C2 (es)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20140112255A (ko) 2013-03-13 2014-09-23 고려대학교 산학협력단 바이러스 생산능이 증가된 세포주 및 그 제조방법
EP2975119B1 (en) * 2013-03-13 2020-03-11 ImmunoMax Co., Ltd. Cell strain having increased virus production ability and production method therefor
KR101678666B1 (ko) * 2014-09-02 2016-11-23 주식회사 이뮤노맥스 Bst2 유전자의 기능이 상실된 세포주를 이용한 바이러스 감염 증진방법
JP6708636B2 (ja) 2014-06-18 2020-06-10 イミュノマックス カンパニー リミテッドＩｍｍｕｎｏｍａｘ Ｃｏ．， Ｌｔｄ． Ｂｓｔ２遺伝子の機能が喪失された細胞株を利用したウィルス感染促進及び産生増進方法
CN107619438B (zh) * 2017-10-11 2021-12-03 广州云启科技有限公司 新型环二核苷酸受体及其激动剂或抑制剂筛选的方法和试剂盒
CN109481685B (zh) * 2019-01-11 2021-05-14 深圳先进技术研究院 Cd317抑制剂在制备治疗肝癌的药物中的应用

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5272263A (en) * 1989-04-28 1993-12-21 Biogen, Inc. DNA sequences encoding vascular cell adhesion molecules (VCAMS)
PL323130A1 (en) * 1996-11-15 1998-05-25 Hoechst Ag Application of heterocyclic compounds in production of a pharmaceutic agent, novel heterocyclic compounds and pharmaceutic agent as such
JP3552898B2 (ja) * 1997-02-28 2004-08-11 中外製薬株式会社 リンパ球の活性化抑制剤
US20020034507A1 (en) * 1997-02-28 2002-03-21 Yasuo Koishihara Inhibitor of lymphocyte activation
JP2003219894A (ja) * 1998-02-25 2003-08-05 Chugai Pharmaceut Co Ltd Ｈｍ１．２４抗原タンパク質をコードするゲノム遺伝子及びそのプロモーター
JP2002338599A (ja) * 2000-12-27 2002-11-27 Sankyo Co Ltd 血中滞留性が向上した生理活性タンパク質およびその調製方法

Also Published As

Publication number Publication date
RU2419629C2 (ru) 2011-05-27
JP2009536952A (ja) 2009-10-22
RU2008131538A (ru) 2010-02-10
BRPI0708042A2 (pt) 2011-05-17
MX2008009830A (es) 2009-05-11
CN101516910A (zh) 2009-08-26
KR20110029181A (ko) 2011-03-22

Similar Documents

Publication Publication Date Title
ZA200707650B (en) Azolylacylguanidines as ß-secretase inhibitors
DE602007002700D1 (en) Interventionsfreies frac-system
EP2078282A4 (en) ELECTRONIC COUPONS
DE602007008085D1 (en) Dihydropyrazolopyrimidinonderivate
DE602007002070D1 (en) 2-pyrazincarboxamidderivate
GB0709295D0 (en) New Zealander
DE602007001601D1 (en) Glasuntersuchung
EP1983992A4 (en) 2-IMINO-BENZIMIDAZOLES
DE602007003855D1 (en) Isothermer reaktor
IL192799A0 (en) Substituted 4-phenylpiperidines
DE602007006989D1 (en) Spiropiperidinderivate
EP2038304A4 (en) BST2 INHIBITORS
IL193143A0 (en) Effectof bst2 inhibitor
EP2084019A4 (en) PAINT SCRAPER
AP2008004724A0 (en) Substituted1-yl)-azolin-2-aryl-1-hetaryl-ethane
DE602007011622D1 (en) Penem-prodrugs
EP2024567A4 (en) TONTAPETE
ZA200903382B (en) Substituted 4-imidazoles
EP2007388A4 (en) OPIOPATHIEN
GB0601979D0 (en) Rests
DK1989111T3 (en) Satellitluftbremseapparat
EP1974618A4 (en) UNDERWEAR
GB0516967D0 (en) Inhibitors
DE502007001126D1 (en) Eiten
GB0625861D0 (en) Modified flexicast/flexisplint